Celecoxib is an inhibitor of enzyme acetylcholinesterase
Language English Country Sweden Media print
Document type Journal Article
PubMed
28263539
PII: NEL370916A18
Knihovny.cz E-resources
- MeSH
- Acetylcholinesterase drug effects MeSH
- Celecoxib pharmacology MeSH
- Cholinesterase Inhibitors pharmacology MeSH
- Cyclooxygenase 2 Inhibitors pharmacology MeSH
- Dithionitrobenzoic Acid MeSH
- Humans MeSH
- Molecular Docking Simulation MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Acetylcholinesterase MeSH
- Celecoxib MeSH
- Cholinesterase Inhibitors MeSH
- Cyclooxygenase 2 Inhibitors MeSH
- Dithionitrobenzoic Acid MeSH
OBJECTIVES: Celecoxib is a nonsteroidal anti-inflammatory drug inhibiting enzyme cyclooxygenase-2 (COX-2). The drug was introduced in 1990s. In the work presented here, affinity of celecoxib to enzyme acetylcholinesterase (AChE) is inferred. METHODS: Inhibition of human AChE by celecoxib was tested using standard spectrophotometric Ellman´s method and extrapolation of experimental data by Dixon plot. Interaction between AChE and celecoxib was also predicted by molecular docking using Swiss dock software. RESULTS: A non-competitive mechanism of inhibition was revealed and equilibrium inhibitory constant equal to 313±40 µmol/l was determined. Comparing to AChE, celecoxib was not proved as an inhibitor of enzyme butyrylcholinesterase (BChE). The lowest ΔG was equal to -7.78 kcal/mol. In this case, celecoxib stacked sulfonamide moiety between TYR 337 and TYR 341 of alfa anionic subsite of active site. Cation-Π interactions appears to be responsible for the inhibition. CONCLUSIONS: Though the here revealed and characterized inhibition has lower effect in real conditions than inhibition of COX-2, the inhibitory effect would be utilized in the next research and development of new AChE inhibitors.